Steve Schonfeld’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-47,623
Closed -$1.19M 2487
2025
Q3
$1.19M Buy
47,623
+38,149
+403% +$821K 0.01% 1294
2025
Q2
$218K Buy
+9,474
New +$219K ﹤0.01% 1763
2023
Q3
Sell
-34,380
Closed -$898K 2188
2023
Q2
$898K Buy
+34,380
New +$908K 0.01% 1015
2023
Q1
Sell
-257,320
Closed -$5.84M 2531
2022
Q4
$5.84M Buy
257,320
+156,212
+155% +$4.35M 0.05% 435
2022
Q3
$3.44M Buy
+101,108
New +$3.74M 0.03% 663
2022
Q2
Sell
-26,025
Closed -$695K 2908
2022
Q1
$695K Buy
+26,025
New +$614K 0.01% 1176
2021
Q3
Sell
-61,500
Closed -$2.73M 2401
2021
Q2
$2.73M Buy
+61,500
New +$2.27M 0.03% 620

Other funds holding PRVA

Steve Schonfeld's PRVA Position: Q4 2025 in Review

Steve Schonfeld sold out of Privia Health (PRVA) in Q4 2025, closing a stake of 47,623 shares — an estimated $1.19M sold.

Steve Schonfeld first reported a position in PRVA in Q2 2021 and held it in 7 quarters. The position peaked at $5.84M in Q4 2022. 276 funds tracked by Wall St. Rank hold PRVA as of Q4 2025.

  • Steve Schonfeld reported no remaining Privia Health position as of Q4 2025 after selling out during the quarter.
  • Steve Schonfeld sold 47,623 Privia Health shares in Q4 2025, an estimated $1.19M.
  • Steve Schonfeld first reported a position in Privia Health in Q2 2021 and held it in 7 quarters.
  • Steve Schonfeld's Privia Health position peaked at $5.84M in Q4 2022.
  • 276 funds tracked by Wall St. Rank held Privia Health as of Q4 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.